Trending

lung disease

Nontuberculous mycobacteria – an emerging public health problem

Nontuberculous mycobacteria – an emerging public health problem

The challenge of treating Nontuberculous mycobacteria.

X

Nontuberculous mycobacteria – an emerging public health problem

https://pharmaphorum.com/views-and-analysis/nontuberculous-mycobacteria-emerging-public-health-problem/

Collaboration the key to success in respiratory research

Collaboration the key to success in respiratory research

Lung research needs support as fifth of UK diagnosed with respiratory condition.

X

Collaboration the key to success in respiratory research

https://pharmaphorum.com/views-and-analysis/collaboration-key-success-respiratory-research/

Biomarker trial to show drug value in rare lung disease

Biomarker trial to show drug value in rare lung disease

Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.

X

Biomarker trial to show drug value in rare lung disease

https://pharmaphorum.com/news/biomarker-trial-show-drug-value-rare-lung-disease/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com